AU2001242190A1 - Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof - Google Patents

Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof

Info

Publication number
AU2001242190A1
AU2001242190A1 AU2001242190A AU4219001A AU2001242190A1 AU 2001242190 A1 AU2001242190 A1 AU 2001242190A1 AU 2001242190 A AU2001242190 A AU 2001242190A AU 4219001 A AU4219001 A AU 4219001A AU 2001242190 A1 AU2001242190 A1 AU 2001242190A1
Authority
AU
Australia
Prior art keywords
psma
prostate
peptides derived
specific membrane
membrane antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242190A
Inventor
Pele Chong
Artur Pedyczak
Charles Dwo Yuan Sia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
AVENTIS PASTEUR
Aventis Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AVENTIS PASTEUR, Aventis Pasteur Ltd filed Critical AVENTIS PASTEUR
Publication of AU2001242190A1 publication Critical patent/AU2001242190A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001242190A 2000-03-31 2001-03-30 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof Abandoned AU2001242190A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19338600P 2000-03-31 2000-03-31
US60193386 2000-03-31
PCT/CA2001/000411 WO2001074845A2 (en) 2000-03-31 2001-03-30 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof

Publications (1)

Publication Number Publication Date
AU2001242190A1 true AU2001242190A1 (en) 2001-10-15

Family

ID=22713432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242190A Abandoned AU2001242190A1 (en) 2000-03-31 2001-03-30 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof

Country Status (3)

Country Link
US (1) US20030027246A1 (en)
AU (1) AU2001242190A1 (en)
WO (1) WO2001074845A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
ES2606537T3 (en) 2001-10-23 2017-03-24 Psma Development Company L.L.C. Antibodies against PSMA
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US20050250700A1 (en) * 2002-03-01 2005-11-10 Sato Aaron K KDR and VEGF/KDR binding peptides
US8623822B2 (en) * 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (en) * 2002-03-01 2007-03-21 Dyax Corp Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7985402B2 (en) * 2002-03-01 2011-07-26 Bracco Suisse Sa Targeting vector-phospholipid conjugates
EP2281004A4 (en) * 2008-04-14 2012-02-15 Proscan Rx Pharma Inc Prostate specific membrane antigen antibodies and antigen binding fragments
WO2013006050A1 (en) * 2011-07-06 2013-01-10 Isa Pharmaceuticals B.V. Peptides inducing or enhancing an immune response against prostate-specific membrane protein (PSMA)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4401796A (en) * 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4373071A (en) * 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4598049A (en) * 1983-08-31 1986-07-01 Systec Inc. General purpose gene synthesizer
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5538886A (en) * 1990-07-11 1996-07-23 New York University Receptor-type phosphotyrosine phosphatase-alpha
JP3027190B2 (en) * 1991-02-22 2000-03-27 アムラド・コーポレイション・リミテッド Diagnosis and treatment of glutamate decarboxylase autoantigen-related disease
US5843456A (en) * 1991-03-07 1998-12-01 Virogenetics Corporation Alvac poxvirus-rabies compositions and combination compositions and uses
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
IL125608A0 (en) * 1998-07-30 1999-03-12 Yeda Res & Dev Tumor associated antigen peptides and use of same as anti-tumor vaccines
WO2001062776A1 (en) * 2000-02-23 2001-08-30 Epimmune Inc. Hla binding peptides and their uses

Also Published As

Publication number Publication date
WO2001074845A2 (en) 2001-10-11
US20030027246A1 (en) 2003-02-06
WO2001074845A3 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
AU2001238070A1 (en) Physical presence digital authentication system (webpage-dependent activation)
AU2001273164A1 (en) Membrane associated protein zupari
TWI317737B (en) Membrane penetrating peptides and uses thereof
AU2002308940A1 (en) Silicon oxide membrane
AU1951201A (en) Peptide antigens
AU2002254558A1 (en) Novel vaccine
AU2001242190A1 (en) Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
AU2002255649A1 (en) Band 3 antigenic peptides, malaria polypeptides and uses thereof
AUPQ712000A0 (en) Antigenic peptide fragments of VapA protein, and uses thereof
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
AU2003228863A1 (en) Immunogenic peptides
AU2000275748A1 (en) Hla-a2.1 binding peptides and their uses
AU2002222075A1 (en) Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof
AU2001248188A1 (en) Immunogenic peptides derived from prostate-specific antigen (psa) and uses thereof
AU2002220924A1 (en) Antibodies, peptides, analogs and uses thereof
AU2001290519A1 (en) Silicone derivatized macromolecules
AU2002236160A1 (en) Immunogenic complex comprising ribosomes
AU2002224379A1 (en) Clasp-2 transmembrane proteins
AU2001290240A1 (en) Polypeptide having phospholipase a2 actiivty
AU2002217863A1 (en) Homing peptide multimers, their preparation and uses
AU2002303093A1 (en) Mycobacterial vaccines
AU2002325299A1 (en) Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
AU2002224056A1 (en) Novel polypeptide
AUPR223600A0 (en) Antigenic polypeptide